UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 541

Sortiert nach

Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment

Oncotarget, 2015-11, Vol.6 (34), p.36603-36614

2015

Volltextzugriff (PDF)

Targeting Deubiquitinases in Cancer

Methods in molecular biology (Clifton, N.J.), 2018-01, Vol.1731, p.295

2018

Volltextzugriff (PDF)

3D Hierarchical, Pyramid-Based Cancer Cell Chip for the Detection of Anticancer Drug Effects

Journal of biomedical nanotechnology, 2016-12, Vol.12 (12), p.2125

2016

Volltextzugriff (PDF)

Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset

Cancer discovery, 2015-11, Vol.5 (11), p.1210-1223

2015

Volltextzugriff (PDF)

Targeting DNA Repair in Cancer: Beyond PARP Inhibitors

Cancer discovery, 2017-01, Vol.7 (1), p.20-37

2017

Volltextzugriff (PDF)

The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology

Oncotarget, 2017-02, Vol.8 (7), p.10883-10890

2017

Volltextzugriff (PDF)

Methods for High-throughput Drug Combination Screening and Synergy Scoring

Methods in molecular biology (Clifton, N.J.), 2018-01, Vol.1711, p.351

2018

Volltextzugriff (PDF)

Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State

Cancer discovery, 2016-03, Vol.6 (3), p.316-329

2016

Volltextzugriff (PDF)

The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance

Oncotarget, 2016-07, Vol.7 (29), p.45745-45756

2016

Volltextzugriff (PDF)

A multicellular spheroid-based drug sensitivity test by scanning electrochemical microscopy

Oncology reports, 2005-06, Vol.13 (6), p.1107

2005

Volltextzugriff (PDF)

Drug Sensitivity Assays of Human Cancer Organoid Cultures

Methods in molecular biology (Clifton, N.J.), 2019, Vol.1576, p.339

2019

Volltextzugriff (PDF)

Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting

Methods in molecular biology (Clifton, N.J.), 2010-01, Vol.624, p.25

Greish, Khaled

2010

Volltextzugriff (PDF)

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma

Oncotarget, 2016-05, Vol.7 (18), p.26307-26330

2016

Volltextzugriff (PDF)

Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase

Oncotarget, 2016-04, Vol.7 (16), p.22460-22473

2016

Volltextzugriff (PDF)

Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells

Oncotarget, 2016-11, Vol.7 (46), p.75104-75117

2016

Volltextzugriff (PDF)

Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues

Oncology reports, 2018-08, Vol.40 (2), p.635-646

2018

Volltextzugriff (PDF)

Effects of curcumin complexes on MDA‑MB‑231 breast cancer cell proliferation

International journal of oncology, 2020-08, Vol.57 (2), p.445-455

2020

Volltextzugriff (PDF)

Drug Screening by Resazurin Colorimetry in Ewing Sarcoma

Methods in molecular biology (Clifton, N.J.), 2021, Vol.2226, p.159

2021

Volltextzugriff (PDF)

A high-throughput functional complementation assay for classification of BRCA1 missense variants

Cancer discovery, 2013-10, Vol.3 (10), p.1142-1155

2013

Volltextzugriff (PDF)

Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance

Medical science monitor, 2017-03, Vol.23, p.1295-1304

2017

Volltextzugriff (PDF)

The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates

Methods in molecular biology (Clifton, N.J.), 2018, Vol.1683, p.355

2018

Volltextzugriff (PDF)

Reverse Docking for the Identification of Molecular Targets of Anticancer Compounds

Methods in molecular biology (Clifton, N.J.), 2021, Vol.2174, p.31

2021

Volltextzugriff (PDF)

Tumor spheroid-based migration assays for evaluation of therapeutic agents

Methods in molecular biology (Clifton, N.J.), 2013, Vol.986, p.253

2013

Volltextzugriff (PDF)

1 – 25 von 541

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAnti-Cancer Agents In Medicinal Chemistry

Nur zeigenGeprüft (Peer-Review)

ThemaAntineoplastic Agents - Pharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(236)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(486)
Drug Screening Assays, Antitumor
(395)
Science & Technology
(308)
Life Sciences & Biomedicine
(288)
Animals
(221)
Cell Line, Tumor
(198)
Mice
(142)
Oncology
(137)
Drug Screening Assays, Antitumor - Methods
(133)
Female
(121)
Tumor Cells, Cultured
(119)
Biological And Medical Sciences
(102)
Medical Sciences
(101)
Cell Proliferation - Drug Effects
(91)
Antineoplastic Agents - Chemical Synthesis
(89)
Antineoplastic Agents - Chemistry
(84)
Cell Survival - Drug Effects
(77)
Antineoplastic Agents - Therapeutic Use
(74)
Cell Biology
(70)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment

Targeting Deubiquitinases in Cancer

3D Hierarchical, Pyramid-Based Cancer Cell Chip for the Detection of Anticancer Drug Effects

Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset

Targeting DNA Repair in Cancer: Beyond PARP Inhibitors

The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology

Methods for High-throughput Drug Combination Screening and Synergy Scoring

Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State

Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC

The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance

A multicellular spheroid-based drug sensitivity test by scanning electrochemical microscopy

Drug Sensitivity Assays of Human Cancer Organoid Cultures

Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma

Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase

Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells

Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues

Effects of curcumin complexes on MDA‑MB‑231 breast cancer cell proliferation

Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations

Drug Screening by Resazurin Colorimetry in Ewing Sarcoma

A high-throughput functional complementation assay for classification of BRCA1 missense variants

Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance

The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates

Reverse Docking for the Identification of Molecular Targets of Anticancer Compounds

Tumor spheroid-based migration assays for evaluation of therapeutic agents

Aktive Filter

Suchergebnisse filtern